As ordered reported by the House Committee on Energy and Commerce on July 17, 2013
H.R. 2094 would authorize the Secretary of Health and Human Services, in awarding asthma-treatment grants, to give preference to states that require schools to:
In addition, to obtain the preference for grants under the bill, states would have to certify that their laws provide civil liability protection to school personnel that administer epinephrine.
The bill would not change the purposes for which the Secretary makes asthma-related grants or the amount of funding available. CBO estimates that implementing H.R. 2094 would not have a significant impact on the federal budget. Enacting H.R. 2094 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply.
H.R. 2094 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act and would impose no costs on state, local, or tribal governments.